The NIDDK continues to fund Delpor's efforts to utilize its NANOPOR™ technology in developing a matchstick-size subcutaneous implant device...
Read moreWe are happy to announce that Travis Blake has joined the Kairos team as the Principal for Physical Sciences,...
Read moreDelpor will be part of the Innovation Zone, a high profile 6,000 square foot exhibit space dedicated to showcasing...
Read moreThis Seed funding allows Holoclara to continue development of their immunotherapy to bring relief to millions of people suffering...
Read moreWe are pleased to announce that Neuro-Bio is the latest company to join the Kairos portfolio, following our investment...
Read moreWe are delighted to announce that Nikos Iatropoulos will be joining the Kairos team as Head of Operations. In...
Read moreWe would like to extend a warm welcome to three new Investment Associates joining the Kairos team: Adnan Husain,...
Read moreWe are delighted to announce that our portfolio company Delpor has been issued another patent by the United States...
Read moreCongratulations to our portfolio company Delpor for receiving a new grant award from the National Institute of Mental Health. The...
Read moreWe are very excited to announce that Behavioral Signals has joined the Kairos portfolio, following our investment in their...
Read more